Work Here?
Ferring Pharmaceuticals
Work Here?
Develops peptide hormone-based medicines and therapies
Ferring Pharmaceuticals
Work Here?
Develops peptide hormone-based medicines and therapies
Overview
Ferring Pharmaceuticals develops medicines that use the body's own peptide hormones, focusing on specialties such as reproductive health, gastroenterology, and urology. Its products range from hormone-based therapies to newer gene-based treatments, such as Adstiladrin for bladder cancer. The company achieves its solutions through research-driven development and manufacturing, including synthetic production of peptide hormones (historically oxytocin and vasopressin) and ongoing expansion of production and clinical programs. Ferring differentiates itself by remaining privately held to pursue a long-term research vision, growing through organic expansion and strategic acquisitions while maintaining a global footprint (over 100 countries, 7,000+ employees). Its goal is to advance therapies that leverage the body's biology to treat diseases more effectively, supported by a sustained investment in R&D and manufacturing, with a future focus on bioengineered and gene-based approaches.
About Ferring Pharmaceuticals
Industries
Biotechnology
Healthcare
Company Size
5,001-10,000
Company Stage
Debt Financing
Total Funding
$302.5M
Headquarters
Saint-Prex, Switzerland
Founded
1950
People at Ferring Pharmaceuticals
People at Ferring Pharmaceuticals who can refer or advise you
Simplify's Take
What believers are saying
- Adstiladrin manufacturing capacity is doubling in Parsippany, NJ, supporting growing demand for this first-in-class bladder cancer gene therapy.
- Ferring's partnership with BCAN and rollout of microbiome diagnostics expands its innovation pipeline in uro-oncology and precision medicine.
- Ferring's 900+ U.S. employees and 3 manufacturing sites for Adstiladrin strengthen its domestic market reach and supply chain resilience.
What critics are saying
- Argentina's AAIP privacy fine and U.S. data breach expose Ferring to existential FDA scrutiny that may block or delay Adstiladrin approval.
- Ferring's 500-job cut under its new Enterprise Model risks slowing pipeline rollout and losing key talent in reproductive health and uro-oncology.
- Ferring faces rising regulatory risk, projected 40–60% in 6–12 months, for patient data use in non-clinical programs, especially in Latin America.
What makes Ferring Pharmaceuticals unique
- Ferring is a private, family-owned biopharma with 50+ years of R&D in reproductive medicine and uro-oncology.
- Ferring pioneered the first FDA-approved intravesical gene therapy for bladder cancer, Adstiladrin, and continues investing in gene-based innovations.
- Ferring uniquely combines global fertility initiatives, like the Ferring-Gallup Global Fertility Monitor, with deep specialty drug portfolios in urology and gastroenterology.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$302.5M
Above
Industry Average
Funded Over
2 Rounds
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Disability Insurance
Life Insurance
401(k) Retirement Plan
401(k) Company Match
Wellness Program
Tuition Reimbursement
Paid Sick Leave
Paid Vacation
Paid Holidays
Parental Leave
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↑ 7%1 year growth
↑ 7%2 year growth
↑ 7%Ferring Service Center expansion. Ferring continues to grow its investment in Portugal. Ferring/AICEP 26/03/2026 The Ferring Service Center has recently expanded its office space, further reinforcing its commitment to offering a healthy, inclusive, and highly collaborative work environment for all employees. This expansion increases its capacity and positions Portugalglobal to continue growing in a strong and sustainable way.
Ferring announces new Ambition, Enterprise Model and Executive Committee composition to accelerate growth and innovation.
Ferring Pharmaceuticals is Hiring for 19 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Ferring Pharmaceuticals
Industries
Biotechnology
Healthcare
Company Size
5,001-10,000
Company Stage
Debt Financing
Total Funding
$302.5M
Headquarters
Saint-Prex, Switzerland
Founded
1950
Ferring Pharmaceuticals is Hiring for 19 Jobs on Simplify!
Find jobs on Simplify and start your career today